Meeting
2020 Gastrointestinal Cancers Symposium
Short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.
Authors
Ali Shamseddine
American University of Beirut Medical Center, Beirut, Lebanon
Ali Shamseddine , Youssef Zeidan , Ibrahim Moustafa Khalifeh , Joseph Gergi Kattan , Rim Turfa , Deborah Mukherji , Sally Naji Temraz , Faek Jamali , Yasser Hani Shaib , Assaad Soweid , Samer Deeba , Malek Kreidieh , Ziad zuheir El Husseini , Maya Charafeddine , Monita Al Darazi , Fady B. Geara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT03503630
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 139)
Abstract #
139
Poster Bd #
G3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Perioperative immunochemotherapy (mDCF + avelumab) in locally advanced gastro-esophageal adenocarcinoma: A phase II trial.
First Author: Thierry Alcindor
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Assessment of immunoscore and MRI tumor regression grade to predict complete pathologic response in patients with locally advanced rectal cancer: Data from phase II Averectal study.
First Author: Ali Shamseddine
Poster
2022 ASCO Gastrointestinal Cancers Symposium
High immunoscore as a predictor of outcome in patients who underwent chemoimmuno-therapy in locally advanced rectal cancer: A post-hoc analysis of the correlation between immunoscore and pCR in the Averectal study.
First Author: Ali Shamseddine
Poster
2021 ASCO Annual Meeting
Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC): The AVANA study.
First Author: Lisa Salvatore